[
    [
        {
            "time": "2019-06-30",
            "original_text": "Here's Why Axsome Therapeutics Stock Rocketed 813% in the First Half of 2019",
            "features": {
                "keywords": [
                    "Axsome Therapeutics",
                    "Stock Rocketed",
                    "813%",
                    "First Half",
                    "2019"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 2,
                "Headline_Structure": 10,
                "Source_Recency": 1
            }
        },
        {
            "time": "2019-06-30",
            "original_text": "Better Buy: Pfizer vs. Johnson & Johnson",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Johnson & Johnson",
                    "Better Buy"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        },
        {
            "time": "2019-06-30",
            "original_text": "Here's Why Axsome Therapeutics Stock Rocketed 813% in the First Half of 2019",
            "features": {
                "keywords": [
                    "Axsome Therapeutics",
                    "Stock Rocketed",
                    "813%",
                    "First Half",
                    "2019"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 9,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 2,
                "Headline_Structure": 10,
                "Source_Recency": 1
            }
        }
    ]
]